Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

STRAX: INTERIM REPORT NO 3 FOR THE FINANCIAL YEAR 2019

STRAX delivers 17% sales growth in Q3 2019 and 18% growth YTD on a like-for-like basis, with significant improvement in profitability.The Group’s sales for the period January 1 – September 30, 2019, amounted toMEUR 72.3 (69.5), corresponding to an increase of 4 percent, with a gross margin of 24.1 (28.6) percent. The Group’s[ ]result for the period January 1 – September 30, 2019, amounted toMEUR -2.5 (-1.1) corresponding to EUR -0.02 (-0.01) per share. The result for the period was negatively affected by MEUR 3.3 related to the decline in value of the Zagg shares. Equity as of

Notice of the Extraordinary General Meeting of the shareholders in Climeon AB (publ)

The shareholders are hereby called to the Extraordinary General Meeting in Climeon AB, 556846-1643,to be held on Tuesday December 17, 2019 at 10.30 hours, at the Company’s premises atTorshamnsgatan 44 in Kista.  Participation, registration etc. Shareholder wishing to participate in the meeting must: · be listed as owner in the company’s share register printed out by Euroclear Sweden AB on Wednesday December 11, 2019, and · have notified the company via e-mail at bolagsstamma@climeon.com or by post to Climeon AB att: Catarina Mellin, Torshamnsgatan 44, 164 40 Kista at the

Dustin Capital Markets Day 2019

Dustin hosts a Capital Markets Day today at the Logistics Center in Rosersberg. The focus of today is to provide a detailed review of the company's strategy and market position, as well as to present an update on what the company has achieved so far in the five-year plan presented on the Capital Markets Day two years ago. At the same time, it is communicated that the financial targets are unchanged.The overall ambition is that Dustin, in line with the company's unchanged financial targets (see below), will continue to drive organic growth of 8 percent over a cycle, supplemented with 3-5

Ahlstrom-Munksjö Oyj considers issuance of capital securities

AHLSTROM-MUNKSJÖ OYJ INSIDE INFORMATION NOVEMBER 28, 2019 at 9:30 EET NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN OR INTO AUSTRALIA, CANADA, HONG KONG, JAPAN, NEW ZEALAND, SINGAPORE, SOUTH AFRICA OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. Ahlstrom-Munksjö is considering the issuance of new euro-denominated capital securities in the expected amount of EUR 75–100 million (the “Capital Securities”). The issuance of the Capital Securities is expected to take place in the near future, subject to market

Interim report 1 Jan-30 Sep 2019

The following summary refers to the period 1/1/2019 – 30/9/2019,  compared to 1/1/2018 – 30/9/2018 · Net sales for this period totaled to SEK 3,134,257(SEK 923,049) · Operating result for the period of SEK -5,843,022 (SEK -5,200,335) · Cash and bank balance SEK 17,107,410 (SEK 9,921,882) · Capitalized development costs of SEK 1,300,758 (SEK 1,218,977) · Average number of registered shares 10,016,035 (9,877,264 shares) · Result per share* SEK -0.58 (SEK -0.53) · Equity Ratio 93.64% (88.09%) *Result per share is calculated on the average number of registered shares

Realfiction Holding AB announces its Q3 Interim Report for July – September 2019

The company announces that the Q3 Interim Report for July – September 2019 is now available. The full report is attached as a separate document and can also be downloaded from the company’s website (www.realfiction.com). A printed copy can be ordered via investor@realfiction.com. Below is a brief summary of the Q3 Interim Report.Important key figures: • 24% decline in total revenue Q3, 2019 compared to Q3, 2018 • 32% decline in gross profit in Q3, 2019 compared to Q3, 2018 • 9% decrease (5 points) in gross profit margin in Q3, 2019 compared to Q3, 2018 • Solvency ratio of 62.9%

Nustay A/S: Publication of interim financial report for January - September 2019

Today, Nustay A/S (“Nustay”) publishes financial report for the period of January – September 2019. The report is available as an attached document to this press release and on the Company’s website (investor.nustay.com). Below is a summary of the report.Mathias Lundoe Nielsen, CEO of Nustay, comments “Our Q3 results highlight what has been a challenging summer season for Nustay. A ‘perfect storm’ of difficulties, ranging from industry-wide challenges to technical issues, have impacted our overall performance throughout the period. Despite this however, Nustay has been able to deliver

Klaria Pharma Appoints Jesper Wiklund as Chief Executive Officer

Stockholm – Jesper Wiklund has been appointed Chief Executive Officer of Klaria Pharma (Klaria) as of November 28, 2019. He brings over 25 years of international commercial experience in the biotechnology and pharmaceutical industry to Klaria. He will succeed Scott Boyer, who will continue his full-time involvement with the company in the newly created role of Chief Scientific Officer.The appointment comes as Klaria enters a new stage of growth with a strong commercial focus. In the coming two years the company will likely receive the approval of its first medicine, Sumatriptan Alginate

STADA collaboration expands in Germany

Enzymatica and its German partner STADA have entered into an agreement for the marketing and sales of a new mouth spray for the German market. The new product is based on the same barrier technology as previous products from Enzymatica. STADA has placed a  first order amounting to SEK 2,3 million. STADA expects to launch the mouth spray in the beginning of 2020.“We are very pleased of STADA launching a mouth spray intended for their own home market. It is very positive that the German consumer gets a chance to use our products,” says Fredrik Lindberg, CEO of Enzymatica. The information

Sectra wins radiology imaging replacement contract at Dutch university hospital

Linköping, Sweden and Almere, the Netherlands – November 28, 2019 – International medical imaging IT and cybersecurity company Sectra  (STO: SECT B) has signed a five-year contract to install its radiology imaging solution at Maastricht University Medical Center (MUMC) in the Netherlands. The solution’s comprehensive toolset helps to streamline the radiology workflow to improve reading efficiency and patient outcomes.The Sectra solution will provide radiologists at MUMC with access to all radiology images, tools and information from a single workstation, anywhere in the

FDA has approved Faron's Clevegen IND

Faron Pharmaceuticals Ltd ("Faron" or the "Company")   Faron receives regulatory approval from FDA to expand MATINS trial for Clevegen into the USA   Company announcement, Turku, Finland, 28 November 2019 at 09 AM (EET)Inside information   TURKU - FINLAND, 28 November 2019 - Faron Pharmaceuticals Ltd ("Faron") (AIM: FARN), the clinical stage biopharmaceutical company, today announces that the US Food and Drug Administration (FDA) has approved the Company's Investigational New Drug (IND) application for Clevegen® (FP-1305), enabling expansion of its ongoing MATINS

­Sale of shares in Lime Technologies AB (publ)

Press release Stockholm 28 November 2019 NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN THE UNITED STATES, CANADA, JAPAN OR AUSTRALIA OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. Monterro 1 AB (“Monterro”) has sold 1,200,000 shares in Lime Technologies AB (publ) ("Lime") through an accelerated bookbuilding to Swedish and international institutional investors at a price of SEK 136.00 per share (“the Placing”). Following the Placing, Monterro owns 1,334,555 shares in Lime, corresponding to 10.05% of the total

Glaston closes deal for automotive pre-processing machines to Chinese customer

Glaston Corporation              Press release            28 November 2019 at 9.00Glaston Group has closed a deal for several pre-processing machines with Chinese Xinyi Glass Holdings Limited, one of the biggest glass companies in China covering float glass, solar glass, coated glass and automotive glass. The deal is put into effect in two phases. The first phase, with a value of approximately EUR 1 million, is booked in Glaston’s Q4/2019 order intake. The machines will be delivered during the early part of 2020. Founded in 1988, Xinyi Glass Holdings Limited currently operates seven

Essity and Fotografiska launch “Power of Hands” exhibition with Malin Fezehai

On November 29, the “Power of Hands” exhibition will open at Fotografiska (the Swedish Museum of Photography) in Stockholm with pictures taken by the internationally award-winning Swedish-Eritrean photographer Malin Fezehai. This will be the third time Essity and Fotografiska hold a joint exhibition aimed at highlighting how hygiene and health affect people’s well-being.Malin Fezehai’s pictures focus on hands and their importance for people. Essity is acting as knowledge partner to the exhibition and is contributing insights into hand hygiene and the link to hygiene, health and well-being

Financial Report 3rd quarter for DOF ASA

The Group’s operating income for 3[rd]quarter (management reporting) totals NOK 2,057 million (NOK 1,739 million) and the operating profit before depreciation and impairment (EBITDA) totals NOK 759 million (NOK 535 million). The Ebitda adjusted for hedge accounting is NOK 803 million (NOK 587 million). Total impairments of NOK 917 million (NOK 124 million) have been booked in the period, hence the operating profit (EBIT) is negative with NOK -503 million (NOK 106 million). The average utilisation of the Group's fleet during the 3rd quarter was 82%; 81% for the subsea fleet, 75% for the

Skanska builds new center for the arts in Beaverton, Oregon, USA, for USD 59 M about SEK 560 M

Skanska has signed a contract with the City of Beaverton to build a new multidisciplinary arts center and adjoining garage in Beaverton, Oregon, USA. The contract is worth USD 59 M, about SEK 560 M, which will be included in the US order bookings for the fourth quarter of 2019.The Patricia Reser Center for the Arts (PRCA) project will include a multidisciplinary arts center, featuring a 550-seat theatre, a large lobby for receptions and events, classrooms and workshops for arts & dance, meeting and conference space, an art gallery, and a café. The 14,400-square-meter Creekside Garage will

Karnov Group reports third quarter results

Good offline sales & JUNO roll-out on trackThird quarter summary · Net sales up 8% to SEK 190 m (176), organic growth was 6%. · EBITA increased to SEK 69 m (60) with EBITA margin of 36.5% (34.2%). · Adjusted EBITA increased by 5.9% to SEK 74 m (70) but adjusted EBITA margin declined by 0.6 percentage points to 38.9% (39.5). · Operating profit (EBIT) increased to SEK 38 m (30). · Earnings per share after dilution amounted to SEK 0.33 (0.12). · Adjusted operating cash flow amounted to SEK 2 m (-12). · Continued roll-out of JUNO, a new joint offering from Norstedts

Systemair's Interim Report for the second quarter will be presented on December 5

Press Release, 28 November 2019 Systemair ABs (NASDAQ OMX Stockholm: SYSR) Interim Report Q2 for the financial year 2019/20 will be published at 08:00 CET on December 5, 2019. A telephone conference will be held at 09:00 CET on December 5, 2019. The report will be presented by Roland Kasper, CEO, and Anders Ulff, CFO. In order to participate in the telephone conference:Call 020-088 36 85 alternative call +46 (0)8-566 426 51 and enter code 53513340 minutes before start. The presentation will be published on group.systemair.com For further information contact:Roland Kasper,

Clinical trial results indicate that Inofer markedly and significantly improved iron uptake, iron saturation and iron stores in patients with heart failure and iron deficiency

Double Bond Pharmaceutical International AB presents the results from a study evaluating Inofer – a medical product against iron deficiency – in patients with heart failure and iron deficiency without having anemia. Current knowledge recommends iron treatment to be given intravenously, as patients with heart failure have so far been regarded to have an insufficient uptake of oral iron treatment. In this pilot study, patients who received oral Inofer (iron succinate) had a markedly and significantly improved iron uptake, with improved iron saturation and iron stores.Iron deficiency occurs in

Veriff launches biometric document verification

Veriff, the most secure global verification service provider launches near-field communication (NFC) verification tool that enables the company to validate ePassport-compatible identity documents with both iOS and Android devices.Veriff now offers ePassports digital verification on all devices that support ePassports reading, including the most recent Android and iOS devices. The new tool speeds up the verification process, is user friendly and makes it more secure than photo-based verification. According to Kaarel Kotkas, Veriff CEO and founder, Veriff is a frontrunner in providing new

Interim report, May–October 2019/20

Good overall growth with fx and delayed installations affecting profitability  We delivered mixed outcomes in the second quarter. Order growth was very strong in emerging markets and North America. Some delayed installations hampered our revenue growth and profitability, although the largest negative impact on profitability came from exchange rate differences. Richard HausmannPresident and CEO Second quarter•    Gross order intake amounted to SEK 4,036 M (3,670), corresponding to a 5 percent organic growth•    Net sales were SEK 3,709 M (3,330), corresponding to a 7 percent

Gränges has signed an agreement to acquire Aluminium Konin

Gränges AB (publ) (“Gränges”) has signed an agreement (the “Agreement”) to acquire the Polish flat rolled aluminium producer Aluminium Konin from Boryszew Group (the “Transaction”). The acquisition strengthens Gränges’ product offering and presence in Europe and contributes with strong positions in new attractive niche markets. Aluminium Konin adds new capabilities and capacity to expand Gränges’ offering for future transportation solutions, such as electric vehicles, and contributes to a stronger position in growing markets. The acquisition is a good strategic fit for Gränges and

There are no items matching the current filter
There are no more items matching the current filter
Back to top